Ankita Paul. Formulation development and evaluation for intranasal L-dopa microsponge targeting brain for Parkinson’s disease.
Chicago-čujuhus (17. p.)Ankita Paul. Formulation Development and Evaluation for Intranasal L-dopa Microsponge Targeting Brain for Parkinson’s Disease.
MLA-čujuhus (9. p.)Ankita Paul. Formulation Development and Evaluation for Intranasal L-dopa Microsponge Targeting Brain for Parkinson’s Disease.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.